Retraction Note: Cellular Oncology (2021) 44:1425–1437
The Editors-in-Chief have retracted this article at the authors’ request. After publication, the authors contacted the journal requesting a correction to Figs. 4 and 5 due to image overlap with their other article, specifically:
Further checks by the Publisher found several additional cases of image overlap in Figs. 2, 4 and 5, as well as other similarities between Figs. 4 and 7 in this article and Fig. 7 in [1]. The authors have provided the underlying raw data for validation, but due to the high number of errors in the published figures, the authors have decided to retract this article.
The authors have been invited to resubmit a corrected version of the article for peer review.
All authors agree to this retraction.
References
T.-H. Li, C. Qin, B.-B. Zhao, H.-T. Cao, X.-Y. Yang, Y.-Y. Wang, Z.-R. Li, X.-T. Zhou, W.-B. Wang, Identification METTL18 as a potential prognosis Biomarker and Associated with Immune infiltrates in Hepatocellular Carcinoma. Front. Oncol. 11, 665192 (2021). https://doi.org/10.3389/fonc.2021.665192
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1007/s13402-021-00651-8.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Li, TH., Zhao, BB., Qin, C. et al. Retraction Note: IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling. Cell Oncol. 46, 1875 (2023). https://doi.org/10.1007/s13402-023-00897-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13402-023-00897-4